Owing to its central role in cellular function, ribosome is one of the most common targets of antibiotics in bacteria. Mutations in rrs gene, ribosomal protein genes, methyltransfersases or drug influx/efflux are often found to overcome the drug response. Despite modulation of methylation pattern in the ribosome through mutations in the methyltransferases as one of key modulators of drug response, rsmG (gidB) is the only conserved methyltransferase associated with low-level drug resistance in large number of mycobacterial isolates. Here, we present the first evidence of association of methylation by mycobacterial RsmE, that methylates U1498 of 16S rRNA, with low levels of drug resistance. Deletion of the RsmE-homolog of Mycobacterium smegmatis leads to at least two-fold increase in the inhibitory concentration of aminoglycosides that bind in the decoding center proximal to U1498 in the 30S subunit. The change in inhibitory concentrations was highly specific and does not show any cross-resistance to drugs of other classes. Surprisingly, Rv2372c, the RsmE-homolog of Mycobacterium tuberculosis has the largest number of mutations among conserved ribosomal methyltransfersases, after gidB, highlighting the role of mutations in the RsmE methyltransferase as a key emerging mechanism of drug resistance in clinical strains of M.
Introduction
M. tuberculosis is one of the most prevalent pathogens and responsible for largest number of deaths by a single infectious pathogen, annually, worldwide (WHO 2018) . Treatment involves multidrug therapy with the four frontline drugs for extended periods of time (Sotgiu et al., 2015) .
However, a rapid increase in resistance towards the first line of drugs, over the last few years, has led to an increased dependence on a prolonged and complex treatment that includes the second line of drugs, namely, fluoroquinolones and injectable aminoglycosides (kanamycin, amikacin, capreomycin) (Sotgiu et al., 2015; WHO 2018) . Any resistance towards the second line of drugs compounds the problem towards extensively drug resistant disease (XDR-TB). Resistance to fluoroquinolones may occur due to mutations in gyrases (Nosova et al., 2013; Zhang and Yew 2015) , to kanamycin by overexpression of eis drug-modifying enzyme (Sowajassatakul et al., 2014; Kambli et al., 2016) or of efflux pumps (Louw et al., 2009; Reeves et al., 2013) , and to other aminoglycosides by modification of target binding site through mutations in rrs (Gygli et al., 2017; Hameed et al., 2018) , ribosomal protein genes (Finken et al., 1993) or changes in rRNA methylation pattern (Buriánková et al., 2004; Maus et al., 2005; Okamoto et al., 2007) .
Methylations in ribosomal RNA are brought about by highly specific rRNA methyltransferases. The complete set of conserved ribosomal methyltransferases has been identified in E. coli and indicates ten conserved methyltransferase members for the 30S subunit (Golovina et al., 2012) . These rRNA methyltransferases are known to modulate the structure of ribosome by addition of methyl group to key nucleotides in the decoding center of ribosome. Mutation in some of the rRNA methyltransferases is associated with altered function of the ribosome as well as with drug resistance. For instance, mutations in gidB, the RsmG 16S rRNA methyltransferase has been reported to be associated with low level resistance towards streptomycin and leads to at least twofold increase in MIC to streptomycin in E. coli and M. tuberculosis (Okamoto et al., 2007; Wong et al., 2011) . Mutations in tlyA, that methylates C1920 in 23S rRNA and C1409 in 16S rRNA, are linked to resistance to capreomycin in M. tuberculosis (Maus et al., 2005) . Despite key roles of methylated nucleotides in the decoding center, Rv3919c (RsmG/GidB, Wong et al., 2011) , Rv2966c (RsmD, Kumar et al., 2011) and Rv2372c (RsmE, Kumar et al., 2014) are the only conserved 30S rRNA methyltransferases identified in M. tuberculosis. Moreover, the role of these methyltransferases in drug resistance, apart from gidB, remains poorly characterized.
We have earlier identified Rv2372c as a RsmE homolog of M. tuberculosis that methylates U1498 in helix 44 of 30S subunit of ribosome in a highly specific manner (Kumar et al., 2014) .
U1498 is one of the conserved methylated nucleotides present in the decoding center of the ribosome that together form a compact hydrophobic cage around the anticodon stem loop structures at the P-site and monitor the codon-anticodon interactions (Korostelev et al., 2006; Selmer 2006) . However, deletion of rsmE had no significant effect on growth and survival of E. coli (Basturea 2006) . Apart from its key roles in ribosomal function and fidelity, U1498 also likely to affect the response to antibiotics, as U1498 lies in the vicinity of binding site of various aminoglycosides as seen in the crystal structures of ribosome-antibiotic complexes (Borovinskaya et al., 2007 (Borovinskaya et al., , 2008 Demirci et al., 2013; Cocozaki et al., 2016) . A mutation of U1498C is among three mutations that confer different levels of hygromycin resistance in M. smegmatis in vitro (Pfister et al., 2003) .
However, this mutation has not been reported in clinical mycobacterial strains. Moreover, the association of methylation at U1498 has not been previously investigated with altered drug response in mycobacteria.
Given the association of antibiotic response with methylated nucleotides in the decoding center, and the key role of helix 44/ U1498 in the P-site of ribosome, here, we investigate the role of methylation by mycobacterial RsmE with antibiotic response by generating a deletion mutant of the RsmE homolog in M. smegmatis. Growth of wild-type, knockout and complemented strain was analyzed with varying concentration of ribosomal-and non-ribosomal-targeting drugs and showed at least two-fold increase in the inhibitory concentration of several antibiotics. Moreover, Rv2372c, the RsmE-homolog of M. tuberculosis was found to harbor the largest number of mutations among conserved ribosomal methyltransfersases, apart from gidB, suggesting a possible correlation of RsmE mutations with drug response in clinical strains. In this work, we show U1498 methylation is conserved in mycobacteria and present the first evidence of association of U1498 methylation with modulation of antibiotic response in any bacteria.
Methods

Mutational analysis of Rv2372c in pathogenic M. tuberculosis strains
Whole genome sequencing data for available 9745 strains of M. tuberculosis were extracted from PATRIC database (www.patricbrc.org, PATRIC March 2019 Release). Rv1010, Rv1407, Rv2966c, Rv2372c, Rv3919c, Rv2165 and Rv1003 were identified as homologs of conserved 16S rRNA methyltransferases of E. coli on the basis of sequence similarity and selected for further analysis. Non-synonymous mutations in the mycobacterial 16S rRNA methyltransferases were identified from genome data of all the strains, with M. tuberculosis H37Rv as the reference strain.
Bacterial strains and growth conditions
M. smegmatis mc 2 155 (Ms-WT) or RsmE-depleted strains (Ms-RsmE) were grown in Difco Middlebrook 7H9 broth or on 7H10 agar plates, supplemented with 0.05% Tween 80, 0.25% glycerol and 0.4% glucose. Growth profiles were obtained by monitoring growth at 600 nm at 37 °C with continuous shaking using the BioScreen growth curve analyzer and plots were generated.
The strains, plasmids and the primers used in the study are listed in Table 1 .
Construction of M. smegmatis knockout and complementation
Rv2372c was earlier identified as the RsmE ortholog in M. tuberculosis (Kumar et al., 2014) . A knockout of MSMEG_4502, the sequence homolog of Rv2372c in M. smegmatis, was generated by a suicidal vector strategy using pPR27, as described earlier (Pelicic et al., 1996; Pelicic et al., 1997) . Briefly, for the targeted gene knockout, the 5' and 3' ends of MSMEG_4502 and its flanking sequences were amplified to generate 'UP' (813 bp) and 'DOWN' (823 bp) fragments. A zeocin resistance gene (657 bp) excised from pMSG360-zeo (Barkan et al., 2010)) was introduced between them to generate UZD (UP-Zeocin-DOWN) deletion cassette. The UZD deletion cassette was then cloned between XbaI and NotI sites in M. smegmatis -E. coli shuttle vector pPR27 yielding plasmid pPR27-MSM_UZD. Plasmid pPR27-MSM_UZD was then transformed into M. smegmatis mc 2 155 via electroporation, to generate the knockout by homologous recombination method.
The pPR27-MSM_UZD transformants of M. smegmatis were selected on 7H10 agar plates containing 10 µg/ml gentamicin and 40 µg/ml zeocin. Knockout strains were selected by growing at 42 °C to promote loss of the plasmid as it has a temperature sensitive origin of replication, Ori_Myco_TS. The knockouts were screened by a two-step selection method. Firstly, the mutants were grown at 42 °C on 7H10 plates along with 10% sucrose for positive selection of knockouts that have lost sacB gene. Mutants were further screened through negative selection by growing on 7H10 plates containing 10 µg/ml gentamicin. The gene knockout of MSMEG_4502 was finally confirmed by PCR for incorporation of UZD disruption cassette and the knockout strain designated as Ms-RsmE.
For complementation of the knockout strain, MSMEG_4502 was cloned in pTC0X1L (Guo et al., 2007; Klotzsche et al., 2009) as well as in pSMT3 expression vector (Gaora et al., 1997) and designated as Ms-RsmE/RsmE or Ms-RsmE/RsmE', respectively. Ms-RsmE/RsmE' was used for complementation when the response with kanamycin and neomycin was tested. pTC-MCS (Klotzsche et al., 2009) or pSMT3 were used as parent vector controls along with indicated antibiotics for both wild type or knockout strain.
In-vivo methylation assay
To test the activity of MSMEG_4502 in M. smegmatis cells, primer extension assay was carried out (Kumar et al., 2014) . Briefly, total RNA was isolated from the M. smegmatis strains and 16S rRNA was gel purified from the total RNA. A primer was synthesized, complementary to the sequence 1497 to 1515 of 16S rRNA of M. smegmatis (corresponding to 1513 to 1531 of E. coli 16S rRNA). The primer was labelled at 5' end with 32 P-labelled ATP, using T4 Polynucleotide kinase. Primer extension was done using Verso reverse transcriptase as per the manufacturer's protocol. The reaction was terminated by heating at 80 ºC for 15 minutes and the products were analysed by running on a 15% urea-PAGE. The gel was further imaged by phosphorimaging. The expected size of the product is 33 bp long if U1482 is methylated (1483 bp to 1515 bp). U1482 of M. smegmatis 16S rRNA (NCBI Accession No. NC_008596.1:c5029475-5027948) corresponds to U1498 of E. coli 16S rRNA (NCBI Accession No. NC_000913.3:4166659-4168200 ). An oligonucleotide of 33 bp size was 5' end labelled with 32 P and used as an indicative size marker.
Phenotypic Characterisation of knockout strains
For the growth assay, Ms-WT, Ms-RsmE or Ms-RsmE/RsmE were grown till an OD (600 nm) of ~ 1.0 at 37 ºC. It was then diluted 1:1000 with fresh media and growth was monitored every 2 hours using the Bioscreen growth analyzer.
Growth assay was also performed to investigate the effect of stress conditions on the growth of knockout. For this, M. smegmatis strains were grown in 7H9 media along with varying concentrations of different stress agents, as indicated. Growth under oxidizing conditions was monitored by growing cells in media containing increasing concentrations (0, 0.25, 0.5, 1.25 and 1.5 mM) of hydrogen peroxide while effect of osmotic stress was monitored with increasing concentrations (0, 0.4, 0.6, 0.8 and 1.0 M) of NaCl. Knockout and wild type cells were grown in sodium nitroprusside (0, 10, 20, 30, 40 and 50 mM) to monitor SNP-mediated stress, which is a NO donor and induces nitrosative stress. For acid stress, knockout or wild type strains were grown in 7H9 media at pH 6.0, pH 5.5, pH 5.0 or pH 4.5.
Drug sensitivity of knockout strain
Drug sensitivity of the knockout strain was tested by microbroth dilution method. Briefly, M. smegmatis strains, Ms-WT, Ms-RsmE and Ms-RsmE/RsmE (or Ms-RsmE/RsmE') were first grown until OD (600nm) ~ 1.0 at 37 ºC. The respective strains were then diluted 1:1000 with fresh media and grown with serial dilution of indicated antibiotics added to the culture. Untreated culture and blank media was taken as positive and negative control, respectively. The growth was monitored at 600 nm every 2 hours at 37 °C with continuous shaking in the Bioscreen growth analyzer. The growth curve was plotted using the average value of three replicates. MIC was reported as the lowest drug concentration showing no visible growth in the respective antibiotics.
Antibiotics used in the study belonged to the following three groups: 30S ribosomaltargeting drugs -kanamycin, amikacin, gentamicin, neomycin, paromomycin, tetracycline and streptomycin; 50S ribosomal-targeting drugs -chloramphenicol and erythromycin and nonribosomal-targeting drugs -moxifloxacin and rifampicin.
Results
Generation of rsmE knockout of M. smegmatis
MSMEG_4502, was identified as the homolog of RsmE of E. coli (e-value: 4e -26) and
Rv2372c of M. tuberculosis (e-value: 3e -107 ) on the basis of sequence similarity. Knockout of MSMEG_4502 in M. smegmatis was generated with the help of a suicidal vector strategy ( Figure   1A ) as described in the Methods section. The mutants were screened and confirmed by PCR ( Figure   1B ) as well as by DNA sequencing. For confirmation by PCR, primers were designed flanking the UP and DOWN fragments (primer F1 and primer F2, Table 1 , respectively). An expected amplified product size of 2535 bp in the knockout (lane 1) as compared to that of 2160 bp in Ms-WT (lane 2), confirms the successful knockout of MSMEG_4502 in M. smegmatis to generate Ms-RsmE.
In-vivo methylation of 16S rRNA by MSMEG_4502 in M. smegmatis
The methylation status at U1498 of 16S rRNA by the mycobacterial homolog was examined by primer extension assay on purified 16S ribosomal RNA extracted from the wild-type (Ms-WT), knockout (Ms-RsmE) and complemented (Ms-RsmE/RsmE) strains. Methylation occurs at N-3 position of U, disrupting hydrogen-bonding with a complemetary A-nucleotide during reverse transcription. A primer extension by reverse transcriptase hence stops 3' to the methylated m 3 U. As seen in Figure 2 , extension of primer (Primer A, Table 1 ) complementary to 1497 to 1515 by reverse transcriptase stops at U1483 if U1482 is methylated (equivalent to U1498 of E. coli 16S rRNA) resulting in a 33 bp product in wild type and complemented strains while reverse transcriptase reads through position 1482 to yield longer products in Ms-RsmE ( Figure 2B ).
Hence, MSMEG_4502 is the RsmE-homolog in M. smegmatis that specifically methylates the equivalent m 3 U1498 position in 16S rRNA in M. smegmatis.
Effect on growth of Ms-RsmE in the absence of U1498 methylation
M. smegmatis strains Ms-WT and Ms-RsmE, with respective empty vector controls, along with Ms-RsmE/RsmE were grown in 7H9 media at 37 °C and growth monitored at OD (600 nm) in the Bioscreen growth analyzer. Ms-RsmE showed slightly slower growth as compared to Ms-WT ( Figure 3 ) that is partially restored in the complemented strain.
The growth of Ms-RsmE was also monitored under different stress conditions. Effect of oxidative stress, osmotic stress, SNP induced stress and acid stress on the growth of Ms-WT, Ms-RsmE and Ms-RsmE/RsmE strains were examined. For effect on growth of Ms-RsmE, under oxidative stress, cells were grown in the presence of increasing concentrations of hydrogen peroxide. Deletion of the RsmE-homolog showed no significant difference on growth under oxidative stress conditions and the growth of Ms-RsmE was largely similar to Ms-WT ( Figure   4A ). To induce osmotic stress to the mycobacterial strains, cells were grown in increasing concentrations of sodium chloride and growth was monitored by OD 600 . Ms-RsmE showed similar growth as Ms-WT under osmotic stress as well ( Figure 4B ). The growth of Ms-RsmE was slow in response to sodium nitroprusside, a nitrosative stress agent which induces stress by generating NO inside the cells ( Figure 4C ).
The growth of Ms-RsmE as a function of decreasing pH, however, was more dramatic.
Ms-WT showed slower growth as pH of the media was varied from pH 6.8 to pH 4.5. However growth of Ms-RsmE, at pH 5.5 or lower was severely compromised compared to the Ms-WT cells ( Figure 4D ). The growth was restored similar to Ms-WT in the complemented Ms-RsmE/RsmE strain, suggesting that expressing the gene in the knockout can reverse the sensitivity towards acidic stress ( Figure 4D , right panel).
Taken together, these results highlight a possible role of RsmE in the acidic stress that mycobacteria might encounter during infection.
Methylation at U1498 can modulate antibiotic response
U1498 is present in helix 44 of 30S subunit and is part of the functional unit, namely, P-site, of ribosome. Aminoglycosides and tetracyclines are the two major classes of drugs that bind at the functional site of 30S subunit of ribosome and were tested for drug susceptibility.
Role of m 3 U1498 methylation in modulating drug response in mycobacteria was monitored by drug susceptibility assays of Ms-WT, Ms-RsmE and Ms-RsmE/RsmE (or Ms-RsmE/RsmE') ( Figure 5 ). Growth in presence of kanamycin shows that a two fold higher concentration is required for growth inhibition of Ms-RsmE as compared to Ms-WT ( Figure 5A ).
In the MSMEG_4502 expressing complement strain, the growth inhibition was restored to similar kanamycin concentrations as Ms-WT, suggesting the difference of growth is associated with the methylation at U1498 ( Figure 5A , right panel).
At least two fold higher concentration of drugs for growth inhibition is also required with amikacin ( Figure 5B ), gentamicin ( Figure 5C ) and paromomycin ( Figure 5D ) as compared to Ms-WT, which are restored in the Ms-RsmE/RsmE complemented strain. Although a two fold higher concentration for growth inhibition is also required with neomycin ( Figure 5E ), it was not restored in the complemented strain.
The growth response of Ms-WT, Ms-RsmE, Ms-RsmE/RsmE with streptomycin ( Figure   5F ) and tetracycline ( Figure 5G ), which bind to A-site of the 30S subunit, farther from helix 44, however, showed no change in inhibitory concentrations.
Deletion of the RsmE-homolog of M. smegmatis hence leads to a low level of resistance to all the tested aminoglycosides that bind in the decoding center proximal to U1498 in helix 44 of 30S subunit of ribosome. The susceptibility is restored to lower concentrations of each aminoglycoside in the respective complemented (Ms-RsmE/RsmE) strain in all cases (except neomycin), suggesting a correlation of methylation at U1498 with drug binding and antibiotic response for aminoglycosides that bind at this site.
Antibiotic response to non-30S targeting drugs
To confirm whether the observed low level resistance was specific to aminoglycosides in Ms-RsmE or did the deleted strain exhibit cross-resistance to any other antibiotics, growth of Ms-WT, Ms-RsmE and Ms-RsmE/RsmE was monitored with non-30S targeting drugs, namely; nonribosomal drugs (rifampicin and moxiflacin) and 50S-targeting drugs (erythromycin and chloramphenicol). Growth of Ms-RsmE with rifampicin ( Figure 6A ) that targets RNA-polymerase and with moxifloxacin ( Figure 6B ) that targets DNA gyrase was similar to that of Ms-WT and the inhibitory concentration for Ms-WT and Ms-RsmE was same for both the drugs.
Growth of Ms-RsmE as compared to Ms-WT was found to be marginally affected by other drugs. Growth was slightly slower in response to erythromycin, that targets 50S subunit at the exit tunnel (Wilson 2014) ( Figure 6C ) but slightly faster in response to chloramphenicol, that targets ribosomal A-site in the 50S subunit (Wilson 2014) ( Figure 6D ). However, no change in inhibitory concentration was observed as compared to Ms-WT for both the drugs. Growth of Ms-RsmE/RsmE complemented strain was similar to that of Ms-WT for all the non-30S targeting drugs ( Figures 6, right panels) .
Hence, the change in inhibitory concentrations, in the knockout strain of M. smegmatis (Ms-RsmE) was specific towards antibiotics belonging primarily to aminoglycoside class among the tested drugs and does not show any cross-resistance to drugs of other classes (Table2).
RsmE mutations are prevalent in the clinical strains of M. tuberculosis
Rv1010, Rv1407, Rv2966c, Rv2372c, Rv3919c, Rv2165 and Rv1003 were identified as homologs of conserved 16S rRNA methyltransferases RsmA, RsmB, RsmD, RsmE, RsmG, RsmH and RsmI, respectively, in 9745 clinical strains of M. tuberculosis in the PATRIC database (Wattam et al., 2017) . Non-synonymous mutations in the mycobacterial 16S rRNA methyltransferases were identified from genome data of all the strains, with M. tuberculosis H37Rv as the reference strain.
Among all methyltransferases, RsmG, which is known to be associated with streptomycin resistance, has mutations in >40% of all strains. Surprisingly, at 19% of all strains with mutations, the RsmE homolog of M. tuberculosis, Rv2372c stands at second position, suggesting a key association of this methyltransferase with clinical manifestation and/or drug response in mycobacteria. Strains with mutations in RsmA, RsmH or RsmI comprised less than 3% of the strains, in each case, while mycobacterial strains carrying mutations in RsmD (Rv2966c) were negligible (Figure 7) .
Discussion
U1498 is localized in the highly conserved region in the top half of helix 44 of 16S rRNA (Schuwirth et al., 2005; Basturea 2006 ). This region is of high functional importance as it is part of the decoding centre. The decoding centre of ribosome ensures error-free selection of cognate tRNA to mRNA, promoting translation accuracy (Ogle et al., 2003; Mahto and Chow 2013) . Antibiotics of several classes, target the decoding centre by binding around helix 44 and inhibiting protein translation (Wilson 2014; Lin et al., 2018) .
Here, in this study, we have shown that methylation of U1498 of 16S rRNA is associated with altered antibiotic response of mycobacterial cells. This response is highly specific towards certain aminoglycosides targeting the 30S subunit of the ribosome. The binding site of these aminoglycosides in the ribosome was mapped from the available crystal structures in the PDB (Figure 8 ). Kanamycin, amikacin, neomicin, gentamicin and paromomycin belong to the class of antibiotics that bind near the top half of the helix 44, close to U1498 in 16S rRNA, whereas streptomycin and tetracycline bind at sites farther away. The fact that only the antibiotics that bind in the vicinity of U1498 exhibited altered growth response of Ms-RsmE in presence of these aminoglycosides, suggests the absence of methylation in the deleted strain affects antibiotic binding at this site. A possible change in the local conformation of the binding site in the absence of m 3 U1498 methylation, might lead to change in the binding pattern of antibiotics, resulting in a low level increased resistance in Ms-RsmE. This is the first report where methylation at U1498 of 16S rRNA is shown to be directly associated with change in the antibiotic response in mycobacteria.
RsmE is widely distributed in major bacterial groups (Baldridge and Contreras 2014; Benítez-Páez et al., 2014) . Despite a reductive evolution of the mycobacterial genomes, conservation of Rv2372c, the RsmE-homolog in M. tuberculosis, suggests m 3 U1498 methylation is necessary for normal cellular physiology. The m 3 U1498 nucleotide interacts directly with the mRNA in the ternary complex of 70S ribosome-mRNA-tRNA of Thermus thermophilus (Korostelev et al., 2006) and E. coli (Selmer 2006) highlighting its role in efficient translation.
Moreover, a U1498G mutation blocks the first peptide bond formation due to possible change in tertiary structure around the decoding structure (Ringquist et al., 1993) .
The crystal structure of 70S ribosome also showed that m 3 U1498 is present in the intersubunit bridge of 50S and 30S and interacts with the conserved regions in 23S rRNA (Selmer 2006; Baldridge and Contreras 2014) . Despite taking part in several key interactions in the assembly and function of ribosome, the RsmE knockout of E. coli grows normally although it fails to compete when grown together with the wild type (Basturea 2006) . In case of M. smegmatis, although the RsmE-homolog, MSMEG_4502, is not essential for its survival, knockout of MSMEG_4502 leads to subtle changes in physiology of the mutant Ms-RsmE strain.
Even a low level resistance in a microorganism in vitro, can serve as a stepping stone to development of high level clinically relevant resistant strains (Gomez et al., 2017) , as seen for streptomycin (Okamoto et al., 2007) . The modulation of antibiotic response by RsmE methyltransferase might lead to a potential threat and hence must be understood in greater details.
Mycobacteria encounter a wide variety of stress, viz., oxidative and pH stress during infection of the host. In a recent report, phagosomal acidification was shown to alter the redox physiology of M.
tuberculosis to promote tolerance of the bacterium to antibiotics (Mishra et al., 2019) . Inhibition of phagosomal acidification by the antimalarial drug chloroquine eradicated drug-tolerant bacilli in in vivo models. The increased sensitivity of Ms-RsmE, lacking methylation at 1498 position, to acid stress, however, suggests an alternate potential combinatorial way to target tubercular bacilli and prevent emergence of resistance to front line drugs.
Overall, we show that absence of methylation of U1498 of 16S rRNA leads to development of low level resistance in M. smegmatis. The increased resistance was specific only for some antibiotics belonging to the aminoglycoside class. Mapping of binding site in the ribosome, showed that growth of Ms-RsmE was affected specifically by aminoglycosides that bind in the vicinity of U1498 of 16S rRNA. We also found that RsmE has the second highest mutation rate in the clinical strains among all conserved methyltransferases. This reinforces the possibility of association of RsmE towards development of resistance in clinical strains of M. tuberculosis, which must be tackled in a timely manner. The Ms-RsmE knockout strain (squares) shows a slightly extended lag phase compared to Ms-WT strain (circles), which is partially restored, similar to Ms-WT, in the complemented strain Ms-RsmE/RsmE (diamonds). The total number of non-synonymous mutations in the coding sequence of the conserved rRNA methyltransferases in the clinical strains of M. tuberculosis obtained from the PATRIC database is indicated. RsmG, having the highest number of mutations, is known to be associated with streptomycin resistance. RsmE methyltransferase has the second highest mutations among conserved methyltransferases, in a total of 19% clinical strains. The conserved E. coli counterpart for each mapped methyltransferase is also indicated. The distance from N-3 of U1498 to the bound drug (closest atom) is indicated in dashed lines (in Å). For clarity, only helix 44 and helix 45 of 30S ribosomal subunit are shown here (cyan). U1498 is indicated as space-filled structure (bright blue). Non-30S targeting drugs are not shown as they bind much farther away from U1498. a: Tobramycin-bound structure is indicative of kanamycin/amikacin binding site, as a kanamycin/amikacin-bound ribosome structure could not be identified in PDB. Table 1 ) is 5'end-labelled with 32 P. In the presence of methylation, the reverse transcription is stalled due to disruption of base pairing, giving a truncated product of 33bp, while in the absence of methylation, reverse transcription continues resulting in longer products. All The Ms-∆RsmE knockout strain (squares) shows a slightly extended lag phase compared to Ms-WT strain (circles), which is partially restored, similar to Ms-WT, in the complemented strain Ms-∆RsmE/RsmE (diamonds). 
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